Veru (VERU) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Veru Revenue Highlights

Main Segment (Y)

Global public health sector

Main Geography (Y)

UNITED STATES

Veru Revenue by Period

Veru Revenue by Year

Date	Revenue	Change
2025-09-30	-	-100.00%
2024-09-30	$16.89M	3.62%
2023-09-30	$16.30M	-58.59%
2022-09-30	$39.35M	-35.76%
2021-09-30	$61.26M	43.83%
2020-09-30	$42.59M	33.92%
2019-09-30	$31.80M	100.47%
2018-09-30	$15.86M	16.18%
2017-09-30	$13.66M	-38.29%
2016-09-30	$22.13M	-32.13%
2015-09-30	$32.60M	33.13%
2014-09-30	$24.49M	-22.15%
2013-09-30	$31.46M	-10.21%
2012-09-30	$35.03M	88.71%
2011-09-30	$18.57M	-16.46%
2010-09-30	$22.22M	-19.32%
2009-09-30	$27.54M	7.45%
2008-09-30	$25.63M	32.68%
2007-09-30	$19.32M	30.33%
2006-09-30	$14.82M	32.82%
2005-09-30	$11.16M	26.42%
2004-09-30	$8.83M	-2.39%
2003-09-30	$9.05M	7.47%
2002-09-30	$8.42M	25.32%
2001-09-30	$6.72M	16.46%
2000-09-30	$5.77M	22.30%
1999-09-30	$4.72M	-13.50%
1998-09-30	$5.45M	86.92%
1997-09-30	$2.92M	41.28%
1996-09-30	$2.06M	-6.17%
1995-09-30	$2.20M	-86.42%
1994-09-30	$16.20M	29.60%
1993-09-30	$12.50M	-

Veru generated - in revenue during NA 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Veru Revenue by Quarter

Date	Revenue	Change
2025-12-31	-	-100.00%
2025-09-30	$247.06K	100.00%
2025-06-30	-	100.00%
2025-03-31	-	100.00%
2024-12-31	-	-100.00%
2024-09-30	$6.66M	68.35%
2024-06-30	$3.95M	-4.39%
2024-03-31	$4.14M	93.17%
2023-12-31	$2.14M	-44.57%
2023-09-30	$3.86M	15.59%
2023-06-30	$3.34M	-49.27%
2023-03-31	$6.59M	162.62%
2022-12-31	$2.51M	-3.12%
2022-09-30	$2.59M	-73.04%
2022-06-30	$9.60M	-26.30%
2022-03-31	$13.03M	-7.83%
2021-12-31	$14.14M	-9.66%
2021-09-30	$15.65M	-11.38%
2021-06-30	$17.66M	32.35%
2021-03-31	$13.34M	-8.73%
2020-12-31	$14.62M	24.41%
2020-09-30	$11.75M	13.83%
2020-06-30	$10.32M	3.81%
2020-03-31	$9.94M	-6.00%
2019-12-31	$10.58M	21.19%
2019-09-30	$8.73M	-10.27%
2019-06-30	$9.73M	39.43%
2019-03-31	$6.98M	9.48%
2018-12-31	$6.37M	22.46%
2018-09-30	$5.20M	-5.42%
2018-06-30	$5.50M	113.84%
2018-03-31	$2.57M	-0.53%
2017-12-31	$2.59M	-29.95%
2017-09-30	$3.69M	-14.41%
2017-06-30	$4.31M	79.34%
2017-03-31	$2.41M	-25.84%
2016-12-31	$3.24M	-8.97%
2016-09-30	$3.56M	-35.92%
2016-06-30	$5.56M	16.51%
2016-03-31	$4.77M	-42.01%
2015-12-31	$8.23M	15.03%
2015-09-30	$7.15M	-8.42%
2015-06-30	$7.81M	-28.83%
2015-03-31	$10.98M	64.85%
2014-12-31	$6.66M	19.90%
2014-09-30	$5.55M	-29.70%
2014-06-30	$7.90M	81.77%
2014-03-31	$4.35M	-35.04%
2013-12-31	$6.69M	39.69%
2013-09-30	$4.79M	-34.22%
2013-06-30	$7.28M	-23.18%
2013-03-31	$9.48M	-4.37%
2012-12-31	$9.91M	-0.01%
2012-09-30	$9.91M	14.50%
2012-06-30	$8.66M	10.53%
2012-03-31	$7.83M	-9.30%
2011-12-31	$8.63M	21.46%
2011-09-30	$7.11M	102.11%
2011-06-30	$3.52M	-17.96%
2011-03-31	$4.29M	17.41%
2010-12-31	$3.65M	-53.19%
2010-09-30	$7.80M	344.64%
2010-06-30	$1.75M	-75.57%
2010-03-31	$7.18M	30.80%
2009-12-31	$5.49M	-30.63%
2009-09-30	$7.91M	13.57%
2009-06-30	$6.97M	-4.82%
2009-03-31	$7.32M	36.95%
2008-12-31	$5.34M	-31.83%
2008-09-30	$7.84M	38.56%
2008-06-30	$5.66M	-11.61%
2008-03-31	$6.40M	-

Veru generated - in revenue during Q1 2026, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Veru Revenue Breakdown

Veru Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Sep 24	Sep 23	Sep 22	Sep 21	Sep 20
Product and Service, Other	-	-	-	-	-
Global public health sector	$14.49M	-	-	-	-
U.S. prescription channel	$2.40M	-	-	-	-
Other Products	-	$13.01K	$2.42K	-	-
Preboost Segment	-	-	-	$862.83K	$2.04M

Veru's latest annual revenue breakdown by segment (product or service), as of Sep 24: Global public health sector (85.78%), and U.S. prescription channel (14.22%).

Quarterly Revenue by Product

Product/Service	Sep 23	Jun 23	Mar 23	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Jun 18	Mar 18
Other Products	$7.72K	$-225.00	$5.52K	-	-	-	-	-	-	-	-	-	-
Preboost Segment	-	-	-	$862.83K	$785.28K	$676.03K	$420.83K	$153.09K	$261.09K	$443.32K	-	-	-
Z	-	-	-	-	-	-	-	-	-	-	$24.00K	$372.00K	$378.00K
U	-	-	-	-	-	-	-	-	-	-	-	$641.00K	$981.00K
Other Countries	-	-	-	-	-	-	-	-	-	-	-	$2.57M	$221.00K
M	-	-	-	-	-	-	-	-	-	-	-	$127.00K	-

Veru's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: Other Products (100.00%).

Veru Revenue Breakdown by Country

Annual Revenue by Country

Country	Sep 24	Sep 22	Sep 21	Sep 20	Sep 19
BRAZIL	$2.76M	-	-	-	-
SOUTH AFRICA	$1.90M	-	-	-	-
Other Geographical Areas	$4.70M	-	-	-	-
MOZAMBIQUE	$2.17M	-	-	-	-
UNITED STATES	$5.35M	-	-	-	-
U	-	$31.43M	$48.94M	$30.34M	$17.26M
Other Countries	-	$7.92M	$12.32M	$12.25M	$14.54M

Veru's latest annual revenue breakdown by geography, as of Sep 24: UNITED STATES (31.71%), Other Geographical Areas (27.81%), BRAZIL (16.35%), MOZAMBIQUE (12.87%), and SOUTH AFRICA (11.26%).

Quarterly Revenue by Country

Country	Jun 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
Other Geographical Areas	$1.53M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
UNITED STATES	$1.11M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
MOZAMBIQUE	$1.32M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Countries	-	$865.11K	$784.64K	$1.28M	$470.31K	$1.44M	$1.94M	$2.58M	$1.18M	$2.23M	$1.76M	$3.57M	$2.73M	$4.26M	$1.99M	$2.74M	$2.27M	$2.48M	$5.76M	$3.31M
Z	-	-	-	$612.00K	$1.33M	$1.18M	$610.00K	-	-	-	-	-	-	-	-	-	-	-	-	-
U	-	-	-	$1.45M	$4.79M	$257.47K	$649.96K	$7.02M	$11.85M	$11.91M	$13.89M	$14.08M	$10.61M	$10.36M	$9.76M	$6.40M	$7.67M	$6.49M	-	-
North America	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$5.55M

Veru's latest quarterly revenue breakdown by geography, as of Jun 24: Other Geographical Areas (38.68%), MOZAMBIQUE (33.32%), and UNITED STATES (28.00%).

Veru Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
CELU	Celularity	$22.77M	$5.28M
DYAI	Dyadic	$3.50M	$1.16M
BTAI	BioXcel Therapeutics	$2.27M	$120.00K
RNXT	RenovoRx	$43.00K	$266.00K
VERU	Veru	-	-
RVPH	Reviva Pharmaceuticals	-	-
BCAB	BioAtla	-	-
MURA	Mural Oncology	-	-
PYPD	PolyPid	-	-
ANVS	Annovis Bio	-	-

VERU Revenue FAQ

What is Veru’s yearly revenue?

Veru's yearly revenue for 2025 was $0, representing a decrease of -100.00% compared to 2024. The company's yearly revenue for 2024 was $16.89M, representing an increase of 3.62% compared to 2023. VERU's yearly revenue for 2023 was $16.3M, representing a decrease of -58.59% compared to 2022.

What is Veru’s quarterly revenue?

Veru's quarterly revenue for Q1 2026 was $0, a -100.00% decrease from the previous quarter (Q4 2025), and a 0% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $247.06K, a 100.00% increase from the previous quarter (Q3 2025), and a -96.29% decrease year-over-year (Q4 2024). VERU's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a -100.00% decrease year-over-year (Q3 2024).

What is Veru’s revenue growth rate?

Veru's revenue growth rate for the last 3 years (2023-2025) was -100.00%, and for the last 5 years (2021-2025) was -100.00%.

What are Veru’s revenue streams?

Veru's revenue streams in p 24 are Global public health sector, and U.S. prescription channel. Global public health sector generated $14.49M in revenue, accounting 85.78% of the company's total revenue U.S. prescription channel generated $2.4M in revenue, accounting 14.22% of the company's total revenue

What is Veru’s main source of revenue?

For the fiscal year ending Sep 24, the largest source of revenue of Veru was Global public health sector. This segment made a revenue of $14.49M, representing 85.78% of the company's total revenue.